Glucocorticoid Receptor

The glucocorticoid receptor (GR, or GCR) also known as NR3C1 (nuclear receptor subfamily 3, group C, member 1) is the receptor to which cortisol and other glucocorticoids bind.

The GR is expressed in almost every cell in the body and regulates genes controlling the development, metabolism, and immune response. Because the receptor gene is expressed in several forms, it has many different (pleiotropic) effects in different parts of the body.

When glucocorticoids bind to GR, its primary mechanism of action is the regulation of gene transcription. ree full text/ref> The unbound receptor resides in the cytosol of the cell. After the receptor is bound to glucocorticoid, the receptor-glucocorticoid complex can take either of two paths. The activated GR complex up-regulates the expression of anti-inflammatory proteins in the nucleus or represses the expression of pro-inflammatory proteins in the cytosol (by preventing the translocation of other transcription factors from the cytosol into the nucleus).

In humans, the GR protein is encoded by gene which is located on chromosome 5 (5q31).

Structure

Like the other steroid receptors, the glucocorticoid receptor is modular in structure and contains the following domains (labeled A - F):
* A/B - N-terminal regulatory domain
* C - DNA-binding domain (DBD)
* D - hinge region
* E - ligand-binding domain (LBD)
* F - C-terminal domain

Ligand binding and response

In the absence of hormone, the glucocorticoid receptor (GR) resides in the cytosol complexed with a variety of proteins including heat shock protein 90 (hsp90), the heat shock protein 70 (hsp70) and the protein FKBP4 (FK506-binding protein 4). The endogenous glucocorticoid hormone cortisol diffuses through the cell membrane into the cytoplasm and binds to the glucocorticoid receptor (GR) resulting in release of the heat shock proteins. The resulting activated form GR has two principal mechanisms of action, transactivation and transrepression, described below.

Transactivation

A direct mechanism of action involves homodimerization of the receptor, translocation via active transport into the nucleus, and binding to specific DNA responsive elements activating gene transcription. This mechanism of action is referred to as transactivation. The biological response depends on the cell type.

Transrepression

In the absence of activated GR, other transcription factors such as NF-κB or AP-1 themselves are able to transactivate target genes. However activated GR can complex with these other transcription factors and prevent them from binding their target genes and hence repress the expression of genes that are normally upregulated by NF-κB or AP-1. This indirect mechanism of action is referred to as transrepression. GR transrepression via NF-κB and AP-1 is restricted only to certain cell types, and is not considered the universal mechanism for IκBα repression.

Clinical significance

The GR is abnormal in familial glucocorticoid resistance.

In central nervous system structures, the glucocorticoid receptor is gaining interest as a novel representative of neuroendocrine integration, functioning as a major component of endocrine influence - specifically the stress response - upon the brain. The receptor is now implicated in both short and long-term adaptations seen in response to stressors and may be critical to the understanding of psychological disorders, including some or all subtypes of depression and post-traumatic stress disorder (PTSD). ree full text/ref> Indeed, long-standing observations such as the mood dysregulations typical of Cushing's disease demonstrate the role of corticosteroids in regulating psychologic state; recent advances have demonstrated interactions with norepinephrine and serotonin at the neural level. ree full text/ref>

In preeclampsia (a hypertensive disorder commonly occurring in pregnant women), the level of a miRNA sequence possibly targeting this protein is elevated in the blood of the mother. Rather, the placenta elevates the level of exosomes containing this miRNA, which can result in inhibition of translation of molecule. Clinical significance of this information is not yet clarified.

Agonists and antagonists

Dexamethasone and other corticosteroids are agonists, while mifepristone and ketoconazole are antagonists of the GR.

Interactions

Glucocorticoid receptor has been shown to interact with:

* BAG1,
* CEBPB,
* CREBBP,
* DAP3,
* DAXX,
* HSP90AA1,
* HNRPU,
* MED1,
* MED14,
* Mineralocorticoid receptor,
* NRIP1,
* NCOR1,
* NCOA1,
* NCOA2,
* NCOA3,
* POU2F1,
* RANBP9,
* RELA,
* SMAD3,
* SMARCD1,
* SMARCA4
* STAT3,
* STAT5B,
* Thioredoxin,
* TRIM28, and
* YWHAH.

Research

A paper published on 28 June 2022 demonstrated that NR3C1 may be one of the potential targets of ALS. It is found that NR3C1 is upregulated in both CNS fALS and sALS using an AI-enabled biological target discovery platform. With target discovery, several pathways and drugs can be further designed to treat ALS.

See also

* Membrane glucocorticoid receptor
* Selective glucocorticoid receptor agonist (SEGRA)

References

Further reading

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

External links

Human Protein Reference Database

*
*
*

{{Glucocorticoidics

Genome projects
3